ESR1 and neoplasm: In multivariate analyses, we demonstrated an independent prognostic effect of tumor size, incompletely administered chemotherapy, ER and PR on DFS and of age, and incomplete chemotherapy on OS within this high-risk group of node-negative breast cancer patients (Table 2).